aTyr Pharma, Inc.

NASDAQ:LIFE

1.9 (USD) • At close June 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 0.2354.3150.3530010.38600000002.0530.1480.1898.0650.1440.1840.094000000000000000000000
Cost of Revenue 0.770.4070.9930.5860.7550.6970.4140.286000000000000000000000000000000000
Gross Profit -0.5353.908-0.64-0.586-0.7559.689-0.414-0.286000002.0530.1480.1898.0650.1440.1840.094000000000000000000000
Gross Profit Ratio -2.2770.906-1.813000.93300000001111111000000000000000000000
Reseach & Development Expenses 13.36412.75510.3199.849.37914.919.8679.1358.8965.9555.1387.6554.5164.6984.6164.3613.6163.593.7993.3143.3453.5494.2026.4846.155.317.1338.429.2049.14410.39511.3071212.677.7397.5026.5934.3414.413.6384.388
General & Administrative Expenses 3.5073.2042.6493.7183.4083.4263.6253.4493.4822.6852.592.792.6862.2952.0442.1462.592.5161.8832.4212.5322.4142.4753.4764.075.893.6943.4874.0073.3833.474.1264.1153.8133.5743.3962.3291.68901.7251.542
Selling & Marketing Expenses -0.77-0.407000000000000000000000000000000000000000
SG&A 2.7372.7972.6493.7183.4083.4263.6253.4493.4822.6852.592.792.6862.2952.0442.1462.592.5161.8832.4212.5322.4142.4753.4764.075.893.6943.4874.0073.3833.474.1264.1153.8133.5743.3962.3291.6891.8211.7251.542
Other Expenses 1.1491.1981.2731.2160.8350.4270.2470.1630.2240.0790.0590.0530.0470.005-0.088-0.129-0.107-0.171-0.147-0.207-0.26-0.359-0.437-0.452-0.447-0.2740000000-0.010000000
Operating Expenses 16.10115.55212.96813.55812.78718.33613.49212.58412.3788.647.72810.4457.2026.9936.666.5076.2066.1065.6825.7355.8775.9636.6779.9610.2211.210.82711.90713.21112.52713.86515.43316.11516.48311.31310.8988.9226.036.2315.3635.93
Operating Income -16.636-15.959-12.615-13.558-12.787-7.95-13.492-12.584-12.378-8.64-7.728-10.445-7.202-4.94-6.512-6.3181.859-5.962-5.498-5.641-5.877-5.963-6.677-9.96-10.22-11.2-10.827-11.907-13.211-12.527-13.865-15.433-16.115-16.483-11.313-10.898-8.922-6.03-6.231-5.363-5.93
Operating Income Ratio -70.791-3.698-35.73700-0.7650000000-2.406-44-33.4290.231-41.403-29.88-60.011000000000000000000000
Total Other Income Expenses Net 1.1491.1981.2751.2160.8350.4270.2470.1630.2240.0790.0590.0530.0470.005-0.088-0.129-0.107-0.171-0.147-0.207-0.26-0.359-0.437-0.452-0.447-0.274-0.363-0.231-0.194-0.0290.0460.050.028-0.01-0.016-0.182-0.1490.824-0.4-0.225-0.163
Income Before Tax -15.487-14.761-11.34-12.342-11.952-7.523-13.245-12.421-12.154-8.561-7.669-10.392-7.155-4.935-6.6-6.4471.752-6.133-5.645-5.848-6.137-6.322-7.114-10.412-10.667-11.474-11.19-12.138-13.405-12.615-13.819-15.383-16.087-16.493-11.329-11.08-9.071-6.038-6.631-5.588-6.093
Income Before Tax Ratio -65.902-3.421-32.12500-0.7240000000-2.404-44.595-34.1110.217-42.59-30.679-62.213000000000000000000000
Income Tax Expense 0.004-0.001-0.993-0.004-0.836-0.429-0.248-0.164-0.2250.007-0.331-0.001-0.3010.003-0.301-0.001-0.001-0.51200-0.336-0.179000-0.1610.3630.2310.194-0.049-0.046-0.05-0.028-0.2260.0160.1820.1490.0080.40.2250.163
Net Income -15.491-14.76-11.34-12.338-11.116-7.094-12.997-12.257-11.929-8.559-7.667-10.391-7.151-4.932-6.599-6.4461.753-5.973-5.645-5.848-6.137-6.322-7.114-10.412-10.667-11.474-11.19-12.138-13.405-12.566-13.819-15.383-16.087-16.493-11.329-11.08-9.071-6.038-6.631-5.588-6.093
Net Income Ratio -65.919-3.421-32.12500-0.6830000000-2.402-44.588-34.1060.217-41.479-30.679-62.213000000000000000000000
EPS -0.23-0.25-0.2-0.22-0.27-0.24-0.45-0.44-0.43-0.31-0.42-0.64-0.51-0.47-0.68-0.690.25-1.54-1.47-1.8-2.54-2.92-3.33-4.88-5.01-5.4-6.07-7.14-7.91-7.42-8.16-9.1-9.53-9.78-6.73-10.41-5.63-8.39-9.22-7.77-8.47
EPS Diluted -0.23-0.25-0.2-0.22-0.27-0.24-0.45-0.44-0.43-0.31-0.42-0.64-0.51-0.47-0.68-0.690.25-1.54-1.47-1.8-2.54-2.92-3.33-4.88-5.01-5.4-6.07-7.14-7.91-7.42-8.16-9.1-9.53-9.78-6.73-10.41-5.63-8.39-9.22-7.77-8.47
EBITDA -15.866-15.552-12.615-12.972-12.032-7.95-13.492-12.298-12.08-8.64-7.728-10.087-7.202-4.94-6.512-5.9562.217-5.962-5.157-5.304-5.877-5.963-6.486-9.768-10.036-11.2-10.312-11.502-12.791-12.498-13.689-15.259-15.91-16.483-11.072-10.507-8.564-6.645-5.622-4.93-5.564
EBITDA Ratio -67.515-3.604-35.73700-0.7650000000-2.406-44-31.5130.275-41.403-28.027-56.426000000000000000000000